About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Mayo Clinic
›
Division of Hematology
›
Top Articles
Division of Hematology
Mayo Clinic
8.1K
Articles
237.5K
Citations
3.1
avg. Impact Factor
199
h-index
Most Cited Articles of Division of Hematology in 2008
Title
Journal
Year
Citations
Improved survival in multiple myeloma and the impact of novel therapies
Blood
2008
1.8K
Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms
Leukemia
2008
780
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)
Haemophilia
2008
676
Multiple myeloma
Blood
2008
654
The epidemiology of venous thromboembolism in the community
Arteriosclerosis, Thrombosis, and Vascular Biology
2008
511
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial
Journal of Clinical Oncology
2008
424
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment
Leukemia
2008
355
Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials
Mayo Clinic Proceedings
2008
283
Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma
Journal of Clinical Oncology
2008
278
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia
Blood
2008
254
Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
Leukemia
2008
239
Genetic aberrations and survival in plasma cell leukemia
Leukemia
2008
236
Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival
Leukemia
2008
229
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741
Journal of Clinical Oncology
2008
229
JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials
Leukemia
2008
185
Clinically relevant end points and new drug approvals for myeloma
Leukemia
2008
156
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group
Blood
2008
153
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains
Kidney International
2008
140
Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 Receptor monoclonal antibody CP-751,871 in patients with multiple myeloma
Journal of Clinical Oncology
2008
139
Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials
Mayo Clinic Proceedings
2008
138
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system
Leukemia
2008
120
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas
Leukemia
2008
118
Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders
Blood
2008
115
Risk factors for leukemic transformation in patients with primary myelofibrosis
Cancer
2008
112
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis
American Journal of Hematology
2008
110
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.